Many people remain on starter doses that are intended only for tolerability, not therapeutic effect
Anyone considering retatrutide should assume they will be paying entirely out-of-pocket
Individual results, side effects, eligibility, and long-term outcomes vary
CrossRef MIND diet score and its association with metabolic dysfunction-associated steatotic liver disease and gut microbiota profiles: a cross-sectional study Shengbo Yang, Litao Zhang, Mingli Hu, Weina He Frontiers in Nutrition .2025;[Epub] CrossRef Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver Biomarkers Pietro Torre, Benedetta Maria Motta, Tommaso Sarcina, Mariano Festa, Mario Masarone, Marcello Persico International Journal of Molecular Sciences .2025
Mounjaro is a dual-targeting drug as it also targets the glucose-dependent insulinotropic polypeptide (GIP) receptor, making it the first-in-class GIP/GLP-1 receptor agonist for the treatment of type 2 diabetes
Add supplies and labs: approximately $3,780 total for the first year